feature story
The Universit y of Arizona Dr. Marie A. Chisholm-Burns, professor and head, Department of Pharmacy Practice & Science at The University of Arizona College of Pharmacy, has provided student pharmacists both research and educational experiences related to drug safety in the care of renal transplant recipients. In the area of research, she has conducted studies demonstrating the role of pharmacy services, which included student pharmacists, in reducing adverse drug events, optimizing therapeutic and economic outcomes, and increasing medication access among renal transplant patients. Students were also included on some of the publications involving these topics. Recently, Dr. Chisholm-Burns received a R01 grant from NIH/NIDDK to conduct a randomized controlled trial involving maximizing therapeutic effects of immunosuppressive agents (antirejection medications). She has also delivered
numerous educational programs on the topic of immunosuppressant medication adverse drug reactions to student pharmacists, pharmacy and medical residents, physicians, pharmacists and nurses. She was appointed to the U.S. Food and Drug Administration’s Drug Safety and Risk Management Advisory Committee for a five-year term, which advises the commissioner of food and drugs on risk management and communication, quantitative evaluation, safety, efficacy, and abuse potential of drugs and other substances, and recommends actions to be taken.
The University of Arizona College of Pharmacy Professor and Department Head Dr. Marie A. Chisholm-Burns, fourth from left, has conducted studies demonstrating the role of pharmacy services, which included student pharmacists, in reducing adverse drug events, optimizing therapeutic and economic outcomes, and increasing medication access among renal transplant patients.
academic Pharmacy now  Oct/Nov/Dec 2009
31